Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
| Autor: | Diamant, Michaela, Van Gaal, Luc, Guerci, Bruno, Stranks, Stephen, Han, Jenny, Malloy, Jaret, Boardman, Marilyn K, Trautmann, Michael E |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology June 2014 2(6):464-473 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|